01253nas a2200289   4500000000100000000000100001008004100002100001400043700001900057700001700076700001600093700001900109700002300128700001200151700002200163700002300185700002400208700001700232700002200249700002000271700001600291245011200307856007500419300001200494490000700506520045000513       2020                            d1 aSP Rathod1 aSujai Suneetha1 aTarun Narang1 aAR Bhardwaj1 aSunil K. Gupta1 aSushruth G. Kamoji1 aAshwini1 aSwetalina Pradhan1 aShagufta P. Rather1 aSatyadarshi Patnaik1 aVikas Shanka1 aSridhar Jandhyala1 aP Narasimha Rao1 aSunil Dogra00aManagement of leprosy in the context of COVID‑19 pandemic: Recommendations by SIG leprosy (IADVL academy)  uhttp://www.idoj.in/temp/IndianDermatolOnlineJ113345-2634024_071900.pdf  a345-3480 v113 aRising numbers of COVID‑19 cases in India: The world is facing an unprecedented pandemic of coronavirus (SARS‑CoV‑2)/COVID‑19 with rising numbers being detected in India. The Indian Association of Dermatologists Venereologists and Leprologists (IADVL) Special Interest Group (SIG) on leprosy, with guidance from IADVL academy of Dermatology, has come out with recommendations on the management of leprosy patients in the current context.